Innovation is here.
Long-acting injectable antiretroviral therapy (LAI ART) is transforming HIV care, but many clinics still face real-world hurdles in getting these programs off the ground. From workflow design, to staff training, to patient education, implementing LAI ART takes time, coordination, and the right tools.
ALAI UP helps clinics build and strengthen LAI ART programs with ready-to-use, evidence-based resources. Drawing on insights from clinical partners across the country, we offer customizable materials that simplify your workload and support access to injectable cabotegravir/rilpivirine (iCAB/RPV) and future long-acting options.
We help you put it into practice.
ALAI UP is a Health Resources and Services Administration (HRSA)-funded Special Projects of National Significance (SPNS) and Minority HIV/AIDS Fund Initiative collaboration led by the Aaron Diamond AIDS Research Center at Columbia University Irving Medical Center.